SR

Subhasis Roy

Active Director Director DIN 09332002
DIN 09332002 First appointment Sep 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Subhasis Roy

Data last updated:

Subhasis Roy is a Director at Cordial Biocare Private Limited (since 2021). The company operates in Trading. Cordial Biocare Private Limited reported revenue of ₹13 Lakh (FY 2025).

DIN 09332002
Primary Designation Director
Industry Trading
First Appointment 24 Sep 2021
Oldest Company Age 5 yrs
Largest company Cordial Biocare Private Limited · ₹13 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cordial Biocare Private Limited U51909WB2021PTC248236
Director24 Sep 20212021₹13 Lakh (FY 2025)Active

Board colleagues of Subhasis Roy

NameDINCompanyDesignation
Poulami Paul09332001Cordial Biocare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cordial Biocare Private Limited
Premium access

Shareholding and investment profile for Subhasis Roy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhasis Roy

Subhasis Roy currently holds 1 directorship: Cordial Biocare Private Limited (Director, since 24 Sep 2021, revenue ₹13 Lakh (FY 2025)).

Subhasis Roy was first appointed on 24 Sep 2021 as Director at Cordial Biocare Private Limited.

The current boards of Subhasis Roy's companies include Poulami Paul (Cordial Biocare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available